China Biologic Products to Participate in the Brean Murray Carret & Co. Boston Healthcare 1x1 Conference
TAI'AN, China, Feb. 25 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management team will attend the upcoming Brean Murray Carret & Co. ("BMC") ...
China Biologic Products Appoints New Independent Director
TAI'AN, China, Feb. 4 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that, effective February 4, 2010, the Company has appointed Dr. Xiangmin Cui, to serve as an in...
China Biologic Products Responds to Allegations on Financial Websites
TAI'AN, China, Jan. 27 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today responded to allegations regarding the Company, certain members of its Board of Directors and...
China Biologic Products to Ring NASDAQ Opening Bell
TAI'AN, China, Dec. 10 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today announced that the Company's senior management team will ring the opening bell at the NASDAQ ...
China Biologic Products Approved to List on NASDAQ
TAI'AN, China, Dec. 1 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (Nasdaq: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today announced that the Company has received approval to list its common...
China Biologic Products Announces Third Quarter 2009 Results
TAI'AN, China, Nov. 16 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority- own...
China Biologic Schedules Conference Call to Discuss Third Quarter 2009 Financial Results
TAI'AN CITY, China, Nov. 13 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in China, today announced that the Company will host a conference call at 8:00 a.m....
China Biologic Named to Forbes Magazine's Fifth Annual List of Asia's '200 Best Under a Billion'
TAI'AN CITY, China, Oct. 21 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in China, today announced that the Company was named on Forbes Magazine's fifth annual list of ...
China Biologic Products' Qianfeng Subsidiary Renews GMP Certification
TAI'AN, China, Sept. 29 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on September 2, 2009,...
China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS
TAI’AN, China, Sept. 24 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China ("PRC"), today announced that on September 11, 2009, th...
China Biologic Products to Attend at Susquehanna's Third Annual Beijing Management Summit
The Company will participate on China Pharma-Biotech Panel TAI'AN, Shandong, China, Sept. 10 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Re...
China Biologic Products Appoints Director of Research and Development
TAI'AN, China, Sept. 9 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiarie...
China Biologic Products to Participate in the Rodman & Renshaw Annual Global Investment Conference
TAI'AN, China, Sept. 3 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiarie...
China Biologic Products Announces Record Second Quarter 2009 Results
TAI'AN, China, Aug. 17 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiarie...
China Biologic Products Schedules 2009 Second Quarter Earnings Conference Call
TAIAN CITY, China, Aug. 13 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that it will host a conference call at...
China Biologic Products Hosts its First Forum for Strategy and Development
TAIAN CITY, China, July 16 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company hosted a forum of ind...
China Biologic Products Closes the $9.6 Million Private Placement
TAI'AN CITY, China, June 12 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on June 10, 2009, the Company su...
China Biologic Products Enters Into Private Placement Agreements to Raise $9.6 Million
TAIAN CITY, China, June 8 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China ("PRC"), today announced that the Company has entered into a sec...
China Biologic Products Announces Strong First Quarter 2009 Results
TAI'AN, Shandong, May 18 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), reported strong financial results for the f...
China Biologic Products Announces 2009 First Quarter Results Conference Call
TAI’AN CITY, Shandong, China, May 18 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China ("PRC"), today announced that it will host a conferen...
